ECELLFRANCE offers to assist academics and industrials with the implementation of their preclinical and/or clinical programs in the field of cell-based therapies.
The infrastructure provides services covering the entire MSC-based production and development pipeline:
Clinical batches meeting the European directive 1394/2007 on ATMP
Phenotypic analysis of sub-populations of immune cells
- Osteoarticular diseases
- Auto-immune diseases
- Cutanuous conditions
- Stroke and neurological disorders
Assistance with regulatory dossier
Investigator brochure, IMPD, CRF
+ Assistance with Phase I and II clinical
Design, methodology, statistics, meeting with the French health authorities (CPP).
You may apply by filling the application form.
For more information contact us.